Bright Minds auditor appointment wins 99.94% vote

Nils Bottler, a director nominee, had 774,816 votes withheld, equal to 10.24%.

Rhea-AI Filing Summary

Bright Minds Biosciences Inc. reports results from its annual general meeting held on March 31, 2026. A total of 7,877,637 common shares were voted, representing 80.49% of votes attached to common shares outstanding as of the record date. Votes for the six director nominees were: Ian McDonald, 99.99%; Nils Bottler, 89.76%; Jeremy Fryzuk, 97.62%; Jan Pedersen, 92.48%; David Weiner, 97.61%; and Steve Farr, 100.00%. Shareholders appointed De Visser Gray LLP, Chartered Professional Accountants, as auditor.

Filing Explained

This 6-K incorporates its voting-results report by reference into two existing Form F-3 registration statements, so the meeting results are included in those registration filings.

Key Figures

Common shares voted: 7,877,637 shares Votes represented: 80.49% Votes for Nils Bottler: 6,789,827 votes (89.76%) +3 more

6 metrics

Common shares voted 7,877,637 shares Annual general meeting held March 31, 2026

Votes represented 80.49% Votes attached to common shares outstanding as of the meeting record date

Votes for Nils Bottler 6,789,827 votes (89.76%) Director nominee election

Votes withheld for Nils Bottler 774,816 votes (10.24%) Director nominee election

Votes for auditor appointment 7,872,821 votes (99.94%) Appointment of De Visser Gray LLP as auditor

Votes withheld on auditor appointment 4,816 votes (0.06%) Appointment of De Visser Gray LLP as auditor

Key Terms

record date, Votes Withheld, proxy

3 terms

record date regulatory

"common shares outstanding as of the record date for the Meeting"

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

Votes Withheld regulatory

"4,816 votes WITHHELD, being 0.06%"

proxy regulatory

"Shares voted in person and by proxy"

A proxy is the authorization a shareholder gives to another person or document to cast votes on their behalf at a company meeting. Think of it like handing someone your voting ticket so they can represent your choices on board elections, executive pay, mergers and other big decisions; it matters because proxies determine who controls the company and which proposals pass, directly affecting share value and investor returns.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares voted at Bright Minds Biosciences (DRUG)'s 2026 annual meeting?

A total of 7,877,637 common shares were voted, representing 80.49% of votes attached to common shares outstanding as of the record date.

What were the vote results for Bright Minds Biosciences (DRUG)'s auditor appointment?

De Visser Gray LLP, Chartered Professional Accountants, was appointed auditor. The appointment received 7,872,821 votes for (99.94%) and 4,816 votes withheld (0.06%).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 05:14 PM Accepted by SEC EDGAR 10/02/2026 - 05:14 PM Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File No. 001-40997

BRIGHT MINDS BIOSCIENCES INC.
(Translation of registrant's name into English)

400 N Aberdeen St Suite 900
Chicago, IL 60642
(U.S. Corporate headquarters) 1122 Mainland St #228
Vancouver, BC V6B 5L1
(Canadian Corporate headquarters)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F  [ ]  Form 40-F [ X ]

INCORPORATION BY REFERENCE

Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K are incorporated by reference into our (i) registration statement on Form F-3 (File No. 333-284694) filed on February 5, 2025, and (ii) registration statement on Form F-3 (File No. 333-289851) filed on August 26, 2025.

SUBMITTED HEREWITH

Exhibits
99.1	Report of Voting Results

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BRIGHT MINDS BIOSCIENCES INC.

"Ryan Cheung"                                            

Ryan Cheung
Chief Financial Officer

Date:  October 2, 2026

REPORT OF VOTING RESULTS

Pursuant to Section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations, the following is the report on voting results for the annual general meeting of shareholders of Bright Minds Biosciences Inc. ("the Company") held on March 31, 2026 (the "Meeting").

The Company reports that a total of 7,877,637 common shares were voted at the Meeting, representing 80.49% of the votes attached to the common shares outstanding as of the record date for the Meeting.  Voting results on the resolutions were as follows:

1. Election of Directors

The six nominees for election to the Board of Directors received votes as follows.

Nominee		Votes For		% Votes For		Votes Withheld		% Votes Withheld
Ian McDonald		7,564,151		99.99%		492		0.01%
Nils Bottler		6,789,827		89.76%		774,816		10.24%
Jeremy Fryzuk		7,384,419		97.62%		180,224		2.38%
Jan Pedersen		6,995,861		92.48%		568,782		7.52%
David Weiner		7,384,084		97.61%		180,559		2.39%
Steve Farr		7,564,376		100.00%		267		0.00%

2. Appointment of Auditors 

De Visser Gray LLP, Chartered Professional Accountants, were appointed as the auditor of the Company. Shares voted in person and by proxy represented 7,872,821 votes FOR, being 99.94% and 4,816 votes WITHHELD, being 0.06%.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 10.5 KB